InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Happel David. Director active across 2 companies, notably Raptor Pharmaceutical Corp. Cumulatively, 10 filings have been recorded. Breakdown: 3 buys · 3 sells. Total volume traded: €1.1m. History available since 16 November 2023. The latest transaction was disclosed on 20 July 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Happel David is a declarant linked to 6 filings in total. In the sampled recent filings from 2016-02-11 to 2025-02-07, buy amounts total 66172 EUR and no sell amount is shown, with transactions in Sagimet Biosciences Inc. and Raptor Pharmaceutical Corp.